Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
Project Number1U01CE003482-01
Contact PI/Project LeaderGRAHAM, PHILLIP W Other PIs
Awardee OrganizationRESEARCH TRIANGLE INSTITUTE
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Early exposure to Adverse Childhood Experiences (ACEs), such as parental substance use, increases the
likelihood of future substance use and drug overdose, resulting in an intergenerational cycle of substance-
related ACEs that can continue indefinitely if left uninterrupted. Community-level interventions may moderate
the relationship between ACEs and substance use by providing an array of family support services and
treatments to reduce disparities and improve reach and service linkages in the community. Although
research suggests that effectively decreasing the prevalence and impact of ACEs and substance use
requires addressing both family- and community-level factors in tandem, there is a critical gap within the
evidence base pertaining to interventions that effectively integrate the two factors to prevent substance use
and ACEs. RTI International and its established partners, the New Jersey Prevention Network and
RWJBarnabas Health, will evaluate an intervention integrating New Jersey’s established, evidence-based
Strengthening Families Program (SFP) with clinically trained, trauma-informed Family Advocates (FAs) who
will assist families in accessing community resources. Specifically, this study will use a Hybrid Type 1
effectiveness-implementation design across 20 New Jersey communities experiencing a disproportionate
burden of substance use and ACEs to address the Research Objective: Conduct rigorous evaluations of
prevention approaches implemented within communities that incorporate efforts to mitigate the
harms of ACEs exposure and prevent future ACEs, while aiming to prevent substance use and
overdose. The study has three aims: (1) use a cluster randomized controlled trial to test effectiveness of the
SFP+FA intervention on substance use, overdose, and ACEs in 10 communities compared with SFP only in
10 communities; (2) conduct a robust process evaluation informed by the Consolidated Framework for
Implementation Research to explore implementation barriers and facilitators; and (3) conduct a cost
evaluation to accurately estimate the costs required to implement SFP and SFP+FA and assess the cost-
effectiveness of SFP+FA relative to SFP alone. Findings will provide a roadmap about the best ways to help
disproportionately affected communities prevent substance use, overdose, and ACEs.
Public Health Relevance Statement
PROJECT NARRATIVE
This study will evaluate a novel intervention that integrates family- and community-level factors to mitigate the
harms of Adverse Childhood Experiences (ACEs) exposure and prevent future ACEs while preventing
substance use and overdose. We will test (1) whether this intervention increases referrals and linkages to
community resources, increases positive family functioning, and reduces youth and parent substance use and
ACEs; and (2) if the integrated intervention produces systems-level change vis-à-vis alignment of services and
resources. Our findings will provide insight about the best ways to help disproportionately affected communities
prevent substance use, overdose, and ACEs.
No Sub Projects information available for 1U01CE003482-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01CE003482-01
Patents
No Patents information available for 1U01CE003482-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01CE003482-01
Clinical Studies
No Clinical Studies information available for 1U01CE003482-01
News and More
Related News Releases
No news release information available for 1U01CE003482-01
History
No Historical information available for 1U01CE003482-01
Similar Projects
No Similar Projects information available for 1U01CE003482-01